CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+53.29%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.09B
AUM Growth
+$2.09B
Cap. Flow
-$302M
Cap. Flow %
-14.46%
Top 10 Hldgs %
62.94%
Holding
58
New
8
Increased
12
Reduced
13
Closed
10

Top Buys

1
EYPT icon
EyePoint Pharmaceuticals
EYPT
$65.6M
2
ALXO icon
ALX Oncology
ALXO
$37.7M
3
AUTL
Autolus Therapeutics
AUTL
$32.6M
4
CRGX
CARGO Therapeutics
CRGX
$27.4M
5
SNDX icon
Syndax Pharmaceuticals
SNDX
$25.4M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$82.3M
2
GPCR icon
Structure Therapeutics
GPCR
$53.3M
3
BBIO icon
BridgeBio Pharma
BBIO
$53.2M
4
CBAY
Cymabay Therapeutics
CBAY
$48.4M
5
CABA icon
Cabaletta Bio
CABA
$43.8M

Sector Composition

1 Healthcare 98.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RYTM icon
26
Rhythm Pharmaceuticals
RYTM
$6.75B
$25.3M 1.21%
550,000
-300,000
-35% -$13.8M
ABVX
27
Abivax
ABVX
$6.32B
$22.8M 1.09%
+2,130,000
New +$22.8M
HARP
28
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$22.6M 1.08%
2,349,060
+2,295,000
+4,245% +$22M
SYRE icon
29
Spyre Therapeutics
SYRE
$1.02B
$20.2M 0.96%
+937,080
New +$20.2M
INSM icon
30
Insmed
INSM
$30.3B
$17.8M 0.85%
575,000
– –
IDYA icon
31
IDEAYA Biosciences
IDYA
$2.26B
$16M 0.76%
450,000
-150,000
-25% -$5.34M
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
$15.6M 0.74%
250,000
– –
NGNE icon
33
Neurogene
NGNE
$284M
$14.5M 0.69%
+746,180
New +$14.5M
LBPH
34
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$14.2M 0.68%
2,353,141
– –
PRAX icon
35
Praxis Precision Medicines
PRAX
$980M
$14.1M 0.67%
633,345
-8,866,655
-93% +$267
RCKT icon
36
Rocket Pharmaceuticals
RCKT
$358M
$13.5M 0.64%
450,000
– –
RAPT icon
37
RAPT Therapeutics
RAPT
$187M
$12.3M 0.59%
496,750
+171,750
+53% +$4.27M
IRON icon
38
Disc Medicine
IRON
$2.14B
$7.22M 0.34%
125,000
-100,000
-44% -$5.78M
STOK icon
39
Stoke Therapeutics
STOK
$1.08B
$5.72M 0.27%
1,087,807
– –
VERV
40
DELISTED
Verve Therapeutics
VERV
$4.88M 0.23%
350,000
– –
LNTH icon
41
Lantheus
LNTH
$3.75B
$4.65M 0.22%
+75,000
New +$4.65M
CNTA
42
Centessa Pharmaceuticals
CNTA
$2.13B
$4.47M 0.21%
561,600
– –
BHVN icon
43
Biohaven
BHVN
$1.71B
$3.51M 0.17%
81,963
– –
GHRS icon
44
GH Research
GHRS
$870M
$3.44M 0.16%
593,043
– –
VYNE icon
45
VYNE Therapeutics
VYNE
$8.09M
$3.25M 0.16%
+1,394,336
New +$3.25M
BCAB icon
46
BioAtla
BCAB
$28.7M
$2.91M 0.14%
1,181,115
– –
NMRA icon
47
Neumora Therapeutics
NMRA
$283M
$1.57M 0.08%
92,293
– –
ORTX
48
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-25,664
Closed -$198K
KRTX
49
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-140,000
Closed -$23.7M
ZNTL icon
50
Zentalis Pharmaceuticals
ZNTL
$123M
– –
-700,000
Closed -$14M
1
2
3